코오롱제약
1 known investors
Find your way into 코오롱제약
Sign up to see every warm intro you have to 코오롱제약
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 코오롱제약 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kolon Pharmaceuticals develops pharmaceuticals and runs an oncology drug-discovery platform, using orthotopic transplant animal models and clinical translational research to identify anticancer targets, with a focus on pancreatic and ovarian cancer indications. The South Korean company co-develops new drugs with domestic and international biotech partners.
Investors · 1
Frequently asked questions
- What does 코오롱제약 do?
- Kolon Pharmaceuticals develops pharmaceuticals and runs an oncology drug-discovery platform, using orthotopic transplant animal models and clinical translational research to identify anticancer targets, with a focus on pancreatic and ovarian cancer indications. The South Korean company co-develops new drugs with domestic and international biotech partners.
- Who are 코오롱제약's investors?
- 코오롱제약's investors include Kolon Investment, Inc..